Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
RYTM holding history
Rhythm Pharmaceuticals, Inc. in every 13F filed by Bellevue Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RYTM overviewAll 13F holders of RYTMFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,016
- Value
- $112.8K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,016 | $112.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 1,016 | $88.4K | <0.1% | −6,488−86.5% | Reduced | Holders |
| Q4 2025 | 7,504 | $803.2K | <0.1% | −1,549−17.1% | Reduced | Holders |
| Q3 2025 | 9,053 | $914.3K | <0.1% | −11,853−56.7% | Reduced | Holders |
| Q2 2025 | 20,906 | $1.32M | <0.1% | +5,356+34.4% | Added | Holders |
| Q1 2025 | 15,550 | $823.7K | <0.1% | −8,046−34.1% | Reduced | Holders |
| Q4 2024 | 23,596 | $1.32M | <0.1% | +7,896+50.3% | Added | Holders |
| Q3 2024 | 15,700 | $822.5K | <0.1% | +2,700+20.8% | Added | Holders |
| Q2 2024 | 13,000 | $533.8K | <0.1% | +500+4.0% | Added | Holders |
| Q1 2024 | 12,500 | $541.6K | <0.1% | −20,369−62.0% | Reduced | Holders |
| Q4 2023 | 32,869 | $1.51M | <0.1% | −40,431−55.2% | Reduced | Holders |
| Q3 2023 | 73,300 | $1.68M | <0.1% | +73,300 | New | Holders |